Emerging treatment modalities

Sara Bressler, Mikhaylo Szczupak, Michael E. Hoffer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Mild traumatic brain injury (mTBI) can be associated with a number of neurosensory sequelae. While a number of these can be mild and self-limited, some individuals who suffer from mTBI may have a significant period of diminished function with long-lasting consequences. In addition, there is mounting evidence that long-term chronic brain dysfunction may occur in some of those who suffer even a mild injury. Effective treatments for mTBI could reduce the period of initial disability and protect against long-term consequences. Despite this motivation there has been a little change in the treatment of mTBI for many years. However, as a result of an increase in both public and scientific interests in mTBI, there are a number of new therapies on the horizon. Many of these are in the early (preclinical) stage of development, while others have already undergone successful clinical trials. This chapter reviews the next generation of medicines and therapies that may prove useful in treating mTBI.

Original languageEnglish (US)
Title of host publicationNeurosensory Disorders in Mild Traumatic Brain Injury
PublisherElsevier
Pages393-404
Number of pages12
ISBN (Electronic)9780128123447
ISBN (Print)9780128125489
DOIs
StatePublished - Jan 1 2019

Keywords

  • Cannabanoids
  • HBOT
  • Hypothermia
  • Medical treatment
  • mTBI
  • NAC

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Emerging treatment modalities'. Together they form a unique fingerprint.

Cite this